3 ms·

One good idea I've heard is to reschedule pyschedelics to the same level that commonly used medications for things like ADHD, anti-depressants, etc. are, i.e. S

One good idea I've heard is to reschedule pyschedelics to the same level that commonly used medications for things like ADHD, anti-depressants, etc. are, i.e. Schedule IV. The main effect really would be reducing the barriers to scientific study and clinical trials while retaining some basic barriers to reckless use by people who have no idea of issues such that the dose-response curve is more exponential than linear (e.g. the effect of 500 ug of LSD is not simply 5X the effect of 100 ug of LSD, etc.). A similar approach would be to only supply them in low-dose packages, which would also facilitate ease of microdosing approaches. Using psychedelics should be contemplated as something like driving a car - letting someone who has never driven a car get on the road with no training whatsoever is just not that great of an idea.

clipsy 3y ago
That is how this sort of thing should be handled in a functional country -- unfortunately ours isn't, and even rescheduling cannabis to schedule III (as has been proposed) will inevitably be a massive political fight. Worse: the opponents of rescheduling often hypocritically use the lack of research to justify their opposition. These state-level laws, as awkward as they may occasionally be, open up an opportunity to build a fact-based case for rescheduling (or descheduling) drugs at the federal level in the longer term. I at least don't see any other realistic way of reaching that point.
briHass 3y ago
Point of note that most of the ADHD drugs (stimulants, the ones that work) are Schedule II, which makes them a PITA to obtain, even with lawful prescriptions. Most opiates are in this category as well. Schedule IV is basically the benzos(Xanax)/z-drugs(Ambien), which is ludicrous considering drugs in that category aren't supposed to have much addiction potential. S3 drugs are mostly weak opiates in formulations that help prevent abuse and steroids. For purposes of studies, S1 is the only real deal breaker, because by definition, there are no medical uses for these drugs. The rest of the schedules are roughly equivalent in terms of PITA for studies and research, only nuance with dispensing to patients varies significantly.
deleted 3y ago
[deleted]

clipsy 3y ago

That is how this sort of thing should be handled in a functional country -- unfortunately ours isn't, and even rescheduling cannabis to schedule III (as has been proposed) will inevitably be a massive political fight. Worse: the opponents of rescheduling often hypocritically use the lack of research to justify their opposition. These state-level laws, as awkward as they may occasionally be, open up an opportunity to build a fact-based case for rescheduling (or descheduling) drugs at the federal level in the longer term. I at least don't see any other realistic way of reaching that point.

briHass 3y ago

Point of note that most of the ADHD drugs (stimulants, the ones that work) are Schedule II, which makes them a PITA to obtain, even with lawful prescriptions. Most opiates are in this category as well. Schedule IV is basically the benzos(Xanax)/z-drugs(Ambien), which is ludicrous considering drugs in that category aren't supposed to have much addiction potential. S3 drugs are mostly weak opiates in formulations that help prevent abuse and steroids. For purposes of studies, S1 is the only real deal breaker, because by definition, there are no medical uses for these drugs. The rest of the schedules are roughly equivalent in terms of PITA for studies and research, only nuance with dispensing to patients varies significantly.

deleted 3y ago

[deleted]